Logo image of CDB.CA

CORDOBA MINERALS CORP (CDB.CA) Stock Fundamental Analysis

TSX-V:CDB - CA21852Q6022 - Common Stock

0.78 CAD
-0.02 (-2.5%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

1

Overall CDB gets a fundamental rating of 1 out of 10. We evaluated CDB against 803 industry peers in the Metals & Mining industry. CDB has a bad profitability rating. Also its financial health evaluation is rather negative. CDB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CDB had negative earnings in the past year.
In the past year CDB has reported a negative cash flow from operations.
CDB had negative earnings in each of the past 5 years.
In the past 5 years CDB always reported negative operating cash flow.
CDB.CA Yearly Net Income VS EBIT VS OCF VS FCFCDB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

CDB has a worse Return On Assets (-95.57%) than 73.97% of its industry peers.
Looking at the Return On Equity, with a value of -257.26%, CDB is doing worse than 74.22% of the companies in the same industry.
Industry RankSector Rank
ROA -95.57%
ROE -257.26%
ROIC N/A
ROA(3y)-134.4%
ROA(5y)-168.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDB.CA Yearly ROA, ROE, ROICCDB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CDB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CDB.CA Yearly Profit, Operating, Gross MarginsCDB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for CDB has been increased compared to 1 year ago.
The number of shares outstanding for CDB has been increased compared to 5 years ago.
Compared to 1 year ago, CDB has a worse debt to assets ratio.
CDB.CA Yearly Shares OutstandingCDB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CDB.CA Yearly Total Debt VS Total AssetsCDB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

CDB has an Altman-Z score of -11.51. This is a bad value and indicates that CDB is not financially healthy and even has some risk of bankruptcy.
CDB has a Altman-Z score of -11.51. This is in the lower half of the industry: CDB underperforms 72.48% of its industry peers.
CDB has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CDB (0.11) is worse than 63.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -11.51
ROIC/WACCN/A
WACCN/A
CDB.CA Yearly LT Debt VS Equity VS FCFCDB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

2.3 Liquidity

CDB has a Current Ratio of 3.31. This indicates that CDB is financially healthy and has no problem in meeting its short term obligations.
CDB has a better Current ratio (3.31) than 65.75% of its industry peers.
A Quick Ratio of 3.31 indicates that CDB has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.31, CDB is doing good in the industry, outperforming 66.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.31
CDB.CA Yearly Current Assets VS Current LiabilitesCDB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CDB have decreased by -2.77% in the last year.
EPS 1Y (TTM)-2.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CDB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CDB.CA Price Earnings VS Forward Price EarningsCDB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CDB.CA Per share dataCDB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CDB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORDOBA MINERALS CORP

TSX-V:CDB (8/29/2025, 7:00:00 PM)

0.78

-0.02 (-2.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-04 2025-11-04
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap72.03M
Analysts84.44
Price Target1.33 (70.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.58
P/tB 7.58
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -95.57%
ROE -257.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-134.4%
ROA(5y)-168.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.23%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 3.31
Altman-Z -11.51
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.97%
Cap/Depr(5y)95.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.11%
OCF growth 3YN/A
OCF growth 5YN/A